Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Estimating the burden of undiagnosed CMML: Prevalence by phenotype and cytopenia stratification in NHANES

Arjun Syal, Dahniel Sastow, Douglas Tremblay

Blood (2025) 146 (Supplement 1): 8205.

https://doi.org/10.1182/blood-2025-8205

Published: 2025

Journal Articles

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in acute myeloid leukemia (AML): An analysis of ECOG-ACRIN clinical trials

Douglas Tremblay, Li Chen, Zhuoxin Sun, Chezi Ganzel, Hugo Fernandez, James Foran, Daniel Arber, Hillard Lazarus, Yanming Zhang, Elisabeth Paietta, John Bennett, Jacob Rowe, Mark Litzow, Martin Tallman, Ehab Atallah, Selina Luger

Blood (2025) 146 (Supplement 1): 871.

https://doi.org/10.1182/blood-2025-871

Published: 2025

Journal Articles

Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients

Blood (2025) 146 (Supplement 1): 1026.

https://doi.org/10.1182/blood-2025-1026

Published: 2025

Journal Articles

Characterization of disease presentation and clinical outcomes of chronic myelomonocytic leukemia and myelofibrosis with monocytosis

Patrick Crorkin, John Mascarenhas, Douglas Tremblay

Blood (2025) 146 (Supplement 1): 7348.

https://doi.org/10.1182/blood-2025-7348

Published: 2025

Journal Articles

Disaggregated outcomes of Asian Americans, Native Hawaiian and Pacific Islander populations with Acute Myeloid Leukemia

Erin Feliciano, Douglas Tremblay, Hannah Levavi, Angelica Singh, Juana Martinez, Alberto Busmail, Adrian Go, Yujin Jeong, Hannah Hugo, Youssef Samaha, Diana Marmolejo, Oikigbeme Oikeh, James Wu, Eunice Wang

Blood (2025) 146 (Supplement 1): 4624.

https://doi.org/10.1182/blood-2025-4624

Published: 2025

Journal Articles

Real-world treatment patterns and clinical outcomes in patients with myelofibrosis treated with pacritinib (PAC): Results from the my-PAC study

Douglas Tremblay, Abiola Oladapo, Michael Marrone, Puja Aggarwal, Caleb Paydar, Djibril Liassou, Purvi Suthar, Adina Gegprifti, Gerard Hoehn, Michael Vredenburg, Bruce Feinberg, Naveen Pemmaraju, James Rossetti

Blood (2025) 146 (Supplement 1): 4607.

https://doi.org/10.1182/blood-2025-4607

Published: 2025

Journal Articles

Travel distance to treatment center does not independently impact survival in Acute Myeloid Leukemia (AML): A national cancer database (NCDB) analysis

Ann Mercurio, Thomas Chen, Dahniel Sastow, Grace Van Hyfte, Khadiza Bhuiyan, Hannah Levavi, Douglas Tremblay

Blood (2025) 146 (Supplement 1): 293.

https://doi.org/10.1182/blood-2025-293

Published: 2025

Journal Articles

Disruption of the gut microbiota promotes chronic inflammation in JAK2V617F-driven MPN: Evidence from mouse and human studies

Althea Agdamag, Zixing Huang, Anisa Azatovna Gumerova, Georgii Pevnev, Christoph Schaniel, Paul Frenette, Rahul Patel, Mone Zaidi, Jeffrey Glassberg, Yelena Ginzburg, Douglas Tremblay, Ronald Hoffman, Huihui Li

Blood (2025) 146 (Supplement 1): 360.

https://doi.org/10.1182/blood-2025-360

Published: 2025

Journal Articles

An independent, multi-center analysis of the post-approval utilization and efficacy of pacritinib and momelotinib in patients with myelofibrosis

Andrew Kuykendall, Douglas Tremblay, Anthony Hunter, Pankit Vachhani, Alexander Coltoff, Anand Patel, Ashwin Kishtagari, Jeremy DiGennaro, Dahniel Sastow, Sandra Jones, Jay Jarodiya, Georgio Medawar, Shiv Shah, Naimisha Marneni, Megan Metzger, Ashley Yu, Rami Komrokji, John Mascarenhas

Blood (2025) 146 (Supplement 1): 5600.

https://doi.org/10.1182/blood-2025-5600

Published: 2025

Journal Articles

Low utilization of cancer genetics referrals in newly diagnosed Acute Myeloid Leukemia

Giuseppe Fiorica, Tehilla Brander, Ganesh Sivakumar, Kyle Wiatrowski, Richard Sheppard, Michelle Rudshteyn, Alla Keyzner, Marina Kremyanskaya, Hannah Levavi, Bridget Marcellino, Alan Shih, Lewis R Silverman, John Mascarenhas, Douglas Tremblay, Daniel Nathan, Jonathan Feld

Blood (2025) 146 (Supplement 1): 1085.

https://doi.org/10.1182/blood-2025-1085

Published: 2025

Journal Articles

Maintenance with hypomethylating agent + venetoclax after intensive induction chemotherapy in patients with newly diagnosed Acute Myeloid Leukemia

Georgio Medawar, Kevin Graf, Jean-Sebastien Anoma, Qi Jin Guo, Amy Hockman, Scott McCraney, Julian Weiss, Chenyu Lin, Dahniel Sastow, Douglas Tremblay, Jonathan Alexander, Praneeth Baratam, Alexander Coltoff

Blood (2025) 146 (Supplement 1): 6960.

https://doi.org/10.1182/blood-2025-6960

Published: 2025

Journal Articles

Treatment responses and survival of newly diagnosed older or unfit patients (pts) with IDH1/2-mutated Acute Myeloid Leukemia (AML): An analysis of the MARROW consortium

Blood (2025) 146 (Supplement 1): 1626.

https://doi.org/10.1182/blood-2025-1626

Published: 2025

Journal Articles

Real-world treatment patterns and outcomes in patients with myelofibrosis who presented with thrombocytopenia and anemia at initiation of pacritinib treatment

Naveen Pemmaraju, Abiola Oladapo, Michael Marrone, Puja Aggarwal, Caleb Paydar, Djibril Liassou, Purvi Suthar, Adina Gegprifti, Michael Vredenburg, Bruce Feinberg, James Rossetti, Douglas Tremblay

Blood (2025) 146 (Supplement 1): 725.

https://doi.org/10.1182/blood-2025-725

Published: 2025

Journal Articles

Clinical, cytogenetic, and molecular characteristics of patients with both chronic lymphocytic leukemia and myeloproliferative neoplasm

Graham Wehmeyer, Ryan Jin, Vesna Najfeld, Megan Metzger, Theodora Anagnostou, Patricia Arboleda Ezcurra, Janice Gabrilove, Marina Kremyanskaya, John Mascarenhas, Christian Salib, Ilan Shapira, Jonah Shulman, Suchitra Sundaram, Douglas Tremblay, Adam Kittai

Blood (2025) 146 (Supplement 1): 5674.

https://doi.org/10.1182/blood-2025-5674

Published: 2025

Journal Articles

Treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib following a switch from ruxolitinib: The my-PAC study

Douglas Tremblay, Abiola Oladapo, Michael Marrone, Puja Aggarwal, Caleb Paydar, Djibril Liassou, Purvi Suthar, Adina Gegprifti, Michael Vredenburg, Bruce Feinberg, James Rossetti, Naveen Pemmaraju

Blood (2025) 146 (Supplement 1): 5577.

https://doi.org/10.1182/blood-2025-5577

Published: 2025

Journal Articles

Acute Promyelocytic Leukemia in the Molecular Age

Navin Bhatt, Michelle Becker, Juana Martinez, Hannah Levavi, Kyle Farina, Marina Kremyanskaya, Bridget Kelly Marcellino, Alan Shih, Lewis R. Silverman, Vesna Najfeld, John O. Mascarenhas, Douglas Tremblay, Jonathan Feld

Blood (2024) 144 (Supplement 1): 6131.

https://doi.org/10.1182/blood-2024-211957

Published: 2024

Journal Articles

Extended Vs Standard Hypomethylating Agent Dosing in Combination with Venetoclax in Newly Diagnosed Acute Myeloid Leukemia

Georgio Medawar, Serena Tharakan, Dahniel L Sastow, Vincent Lok, Su Bin Hahn, Preston Perez, Abigail Demers, David M Swoboda, Douglas Tremblay, Alexander Coltoff

Blood (2024) 144 (Supplement 1): 2904.

https://doi.org/10.1182/blood-2024-209414

Published: 2024

Journal Articles

Systematic Review and Meta-Analysis of Spleen Volume Reduction and Overall Survival in Myelofibrosis Patients Treated with JAK-Inhibitors

Dahniel L Sastow, Hannah Goulart, Karen Bedirian, Madhu Mazumdar, Lily Martin, Kyle Farina, John O. Mascarenhas, Douglas Tremblay

Blood (2024) 144 (Supplement 1): 6665.

https://doi.org/10.1182/blood-2024-200228

Published: 2024

Journal Articles

Estimating the Prevalence of Possible Undiagnosed Chronic Myelomonocytic Leukemia in the General Population: An Nhanes Analysis

Dahniel L Sastow, Daniel I. Nathan, Hannah Levavi, Jonathan Feld, Douglas Tremblay

Blood (2024) 144 (Supplement 1): 5182.

https://doi.org/10.1182/blood-2024-197986

Published: 2024

Journal Articles

Anticoagulation Management of Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: A Global Abdominal/Splanchnic Thrombosis Retrospective Observational Study in 486 MPN Patients (GASTRO-MPN)

Blood (2024) 144 (Supplement 1): 16.

https://doi.org/10.1182/blood-2024-199107

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Estimating the burden of undiagnosed CMML: Prevalence by phenotype and cytopenia stratification in NHANES

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in acute myeloid leukemia (AML): An analysis of ECOG-ACRIN clinical trials

Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients

Characterization of disease presentation and clinical outcomes of chronic myelomonocytic leukemia and myelofibrosis with monocytosis

Disaggregated outcomes of Asian Americans, Native Hawaiian and Pacific Islander populations with Acute Myeloid Leukemia

Real-world treatment patterns and clinical outcomes in patients with myelofibrosis treated with pacritinib (PAC): Results from the my-PAC study

Travel distance to treatment center does not independently impact survival in Acute Myeloid Leukemia (AML): A national cancer database (NCDB) analysis

Disruption of the gut microbiota promotes chronic inflammation in JAK2V617F-driven MPN: Evidence from mouse and human studies

An independent, multi-center analysis of the post-approval utilization and efficacy of pacritinib and momelotinib in patients with myelofibrosis

Low utilization of cancer genetics referrals in newly diagnosed Acute Myeloid Leukemia

Maintenance with hypomethylating agent + venetoclax after intensive induction chemotherapy in patients with newly diagnosed Acute Myeloid Leukemia

Treatment responses and survival of newly diagnosed older or unfit patients (pts) with IDH1/2-mutated Acute Myeloid Leukemia (AML): An analysis of the MARROW consortium

Real-world treatment patterns and outcomes in patients with myelofibrosis who presented with thrombocytopenia and anemia at initiation of pacritinib treatment

Clinical, cytogenetic, and molecular characteristics of patients with both chronic lymphocytic leukemia and myeloproliferative neoplasm

Treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib following a switch from ruxolitinib: The my-PAC study

Acute Promyelocytic Leukemia in the Molecular Age

Extended Vs Standard Hypomethylating Agent Dosing in Combination with Venetoclax in Newly Diagnosed Acute Myeloid Leukemia

Systematic Review and Meta-Analysis of Spleen Volume Reduction and Overall Survival in Myelofibrosis Patients Treated with JAK-Inhibitors

Estimating the Prevalence of Possible Undiagnosed Chronic Myelomonocytic Leukemia in the General Population: An Nhanes Analysis

Anticoagulation Management of Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: A Global Abdominal/Splanchnic Thrombosis Retrospective Observational Study in 486 MPN Patients (GASTRO-MPN)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only